RETRACTED: Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?
PK Agrawal, C Agrawal, G Blunden - Molecules, 2022 - mdpi.com
As the world desperately searches for ways to treat the coronavirus disease 2019 (COVID-
19) pandemic, a growing number of people are turning to herbal remedies. The Artemisia …
19) pandemic, a growing number of people are turning to herbal remedies. The Artemisia …
Traditional Chinese medicines against COVID-19: a global overview
CL Yao, WL Wei, JQ Zhang, QR Bi, JY Li… - World Journal of …, 2022 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2, continues to be a global concern. Traditional Chinese medicines …
syndrome coronavirus 2, continues to be a global concern. Traditional Chinese medicines …
Computational bioprospecting guggulsterone against ADP ribose phosphatase of SARS-CoV-2
Coronavirus Disease-2019 (COVID-19) is a highly contagious disease caused by Severe
Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). The World Health Organization …
Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). The World Health Organization …
Advocacy for the Medicinal Plant Artabotrys hexapetalus (Yingzhao) and Antimalarial Yingzhaosu Endoperoxides
C Bailly, JP Hénichart - Molecules, 2022 - mdpi.com
The medicinal plant Artabotrys hexapetalus (synonyms: A. uncinatus and A. odoratissimus)
is known as yingzhao in Chinese. Extracts of the plant have long been used in Asian folk …
is known as yingzhao in Chinese. Extracts of the plant have long been used in Asian folk …
Plants as biofactories for therapeutic proteins and antiviral compounds to combat COVID-19
C England, J TrejoMartinez, P PerezSanchez, U Karki… - Life, 2023 - mdpi.com
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) had a profound impact on the world's health and …
syndrome coronavirus 2 (SARS-CoV-2) had a profound impact on the world's health and …
Current state, strategies, and perspectives in enhancing artemisinin production
The compound artemisinin is attributed to several biological activities including antimalaria
for which it is popularly known. However, its commercial production is hindered by a low …
for which it is popularly known. However, its commercial production is hindered by a low …
The complexity of sesquiterpene chemistry dictates its pleiotropic biologic effects on inflammation
Sesquiterpenes (SQs) are volatile compounds made by plants, insects, and marine
organisms. SQ have a large range of biological properties and are potent inhibitors and …
organisms. SQ have a large range of biological properties and are potent inhibitors and …
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
E Marchesi, V Gentili, D Bortolotti, L Preti… - ACS …, 2023 - ACS Publications
Here, we propose the molecular hybridization of dihydroartemisinin (DHA) and
ursodeoxycholic bile acid (UDCA), approved drugs, for the preparation of antiviral agents …
ursodeoxycholic bile acid (UDCA), approved drugs, for the preparation of antiviral agents …
Chemical and spectroscopic characterization of (Artemisinin/Querctin/Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against …
Abstract A novel Artemisinin/Quercetin/Zinc (Art/Q/Zn) mixed ligand complex was
synthesized, tested for its antiviral activity against coronavirus (SARS-CoV-2), and …
synthesized, tested for its antiviral activity against coronavirus (SARS-CoV-2), and …
Targeting proteases involved in the viral replication of SARS-CoV-2 by sesquiterpene lactones from chicory (Cichorium intybus L.)
MÁ Ávila-Gálvez, C Rafael-Pita, N Fernández… - Food & Function, 2022 - pubs.rsc.org
SARS-CoV-2 is a highly transmissible and pathogenic coronavirus causing a respiratory
disease that emerged in 2019, leading to a public health emergency situation which …
disease that emerged in 2019, leading to a public health emergency situation which …